The BRD2 and BRD4 up-regulation in the GBM models prompted us to better characterize the BET protein involvement in tumor progression, taking advantage of the well-characterized and specific pan-inhibitor JQ1 [36]. The gene discussed is DNER; the disease is glioblastoma.